GlobalGov › Portugal › Award

Gilead Sciences, Lda won Portugal – Pharmaceutical products – Aquisiçao do Medicamento: Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV from Instituto Português de Oncologia do Porto Francisco Gentil, EPE

Instituto Português de Oncologia do Porto Francisco Gentil, EPE · Portugal government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$6.3M
Award Value
April 3, 2026
Award Date
Awarded
Status

Award Overview

Gilead Sciences, Lda was awarded Portugal – Pharmaceutical products – Aquisiçao do Medicamento: Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV by Instituto Português de Oncologia do Porto Francisco Gentil, EPE in Portugal, tracked by GlobalGov. The award is valued at $6.3M. It was awarded on April 3, 2026. Classification: NAICS 33600000. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeGilead Sciences, Lda
Awardee countryPortugal
Awarding agencyInstituto Português de Oncologia do Porto Francisco Gentil, EPE
CountryPortugal
Award value$6.3M
Award dateApril 3, 2026
NAICS33600000
Official sourceView original award record
Last verifiedSeptember 1, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Portugal market overview →Browse open opportunities →

Track every Portugal contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required